{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:09:44Z","timestamp":1789002584455,"version":"build-2803163510"},"reference-count":47,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVES:<\/jats:bold>\n                    To determine the healthcare costs of acute and chronic pain associated with herpes zoster.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>DESIGN:<\/jats:bold>\n                    Retrospective cohort analysis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>SETTING:<\/jats:bold>\n                    Inpatient and outpatient care.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>PARTICIPANTS:<\/jats:bold>\n                    Patients were selected from Medicare, commercial insurance, and Medicaid claims databases if they had a diagnosis of herpes zoster or postherpetic neuralgia (PHN) or were prescribed analgesics after a diagnosis of herpes zoster (possible PHN) and were matched to controls for demographic and clinical factors using propensity scores.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MEASUREMENTS:<\/jats:bold>\n                    One\u2010year excess healthcare expenditures attributable to herpes zoster pain or PHN were calculated for inpatient, outpatient, and prescription drug services.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    For the Medicare cohort, the average excess cost per patient was $1,300 in the year after a diagnosis of herpes zoster with 30 days or fewer of analgesic use and ranged from $2,200 to $2,300 per patient with PHN or possible PHN. Patients with possible PHN were 53% more prevalent than patients with PHN in the Medicare cohort and accounted for half of all excess expenditures. Findings were similar in the younger cohorts with commercial insurance and Medicaid except that costs attributable to PHN and possible PHN were higher, and patients with possible PHN were three to five times as prevalent as patients with PHN.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    Healthcare costs associated with PHN were substantially greater than those associated with herpes zoster pain that resolved within 30 days. The data suggest that as many as 80% of patients with PHN may not be diagnosed with PHN and that these patients account for at least half of PHN expenditures.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2007.01231.x","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T00:54:29Z","timestamp":1180745669000},"page":"1168-1175","source":"Crossref","is-referenced-by-count":62,"title":["Healthcare Costs of Acute and Chronic Pain Associated with a Diagnosis of Herpes Zoster"],"prefix":"10.1111","volume":"55","author":[{"given":"Robert H.","family":"Dworkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec B.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Baser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"9","article-title":"The nature of herpes zoster","volume":"58","author":"Hope\u2010Simpson RE.","year":"1965","journal-title":"A long-term study and a new hypothesis"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp013211"},{"key":"e_1_2_6_4_2","first-page":"571","article-title":"Postherpetic neuralgia","volume":"25","author":"Hope\u2010Simpson RE.","year":"1975","journal-title":"J R Coll Gen Pract"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donohue JG","year":"1995","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268801005921"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10313"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00034-3"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10316"},{"key":"e_1_2_6_11_2","first-page":"2429","article-title":"Phase specific analysis of herpes zoster associated pain data","volume":"20","author":"Arani RB","year":"2001","journal-title":"A new statistical approach"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(02)00393-7"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000123261.00004.29"},{"key":"e_1_2_6_14_2","first-page":"109","volume-title":"Molecular Neurobiology of Pain","author":"Bennett GJ.","year":"1997"},{"key":"e_1_2_6_15_2","first-page":"335","article-title":"The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia","volume":"3","author":"Bowsher D.","year":"1999","journal-title":"A retrospective survey in an elderly population"},{"key":"e_1_2_6_16_2","article-title":"Health care expenditure burden of persisting herpes zoster pain","author":"Dworkin RH","journal-title":"Pain Med"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.09.004"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-5-200609050-00004"},{"key":"e_1_2_6_19_2","first-page":"1524","article-title":"Advances in neuropathic pain","volume":"60","author":"Dworkin RH","year":"2003","journal-title":"Diagnosis, mechanisms, and treatment recommendations"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2004.09.005"},{"key":"e_1_2_6_21_2","first-page":"373","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies","volume":"40","author":"Charlson ME","year":"1987","journal-title":"Development and validation"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00271-5"},{"key":"e_1_2_6_23_2","first-page":"543","article-title":"A psychiatric patient classification system","volume":"27","author":"Ashcraft ML","year":"1989","journal-title":"An alternative to diagnosis-related groups"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2006.00130.x"},{"key":"e_1_2_6_25_2","first-page":"2","article-title":"In search of an unbiased estimate of treatment effect using observational data","volume":"10","author":"Ganguly R","year":"2004","journal-title":"A comparison of propensity scoring and Heckman two stage sample selection models"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jom.0000194161.12923.52"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199406020-00006"},{"key":"e_1_2_6_28_2","first-page":"39","volume-title":"Herpes Zoster and Postherpetic Neuralgia","author":"Dworkin RH","year":"2001"},{"key":"e_1_2_6_29_2","first-page":"344","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials","volume":"5","author":"Coplan PM","year":"2004","journal-title":"Adaptation of the Brief Pain Inventory"},{"issue":"8","key":"e_1_2_6_30_2","first-page":"S52","article-title":"Herpes zoster and quality of life","volume":"45","author":"Lydick E","year":"1995","journal-title":"A self-limited disease with severe impact"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/421942"},{"key":"e_1_2_6_32_2","first-page":"862","article-title":"Varicella vaccination in England and Wales","volume":"88","author":"Brisson M","year":"2003","journal-title":"Cost-utility analysis"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1995.tb04400.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199711030-00007"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ajhp\/54.10.1180","article-title":"Economic evaluation of famciclovir in reducing the duration of postherpetic neuralgia","volume":"54","author":"Huse DM","year":"1997","journal-title":"Am J Health Syst Pharmacol"},{"issue":"1","key":"e_1_2_6_36_2","first-page":"S85","article-title":"Cost effectiveness of newer antiviral agents for herpes zoster","volume":"178","author":"Smith KJ","year":"1998","journal-title":"Is the evidence spotty?"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2003.12.004"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00857-0"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1017\/S095026880400281X"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-5-68"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1006\/bulm.1999.0126"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2002.0988"},{"key":"e_1_2_6_43_2","first-page":"S31","article-title":"Varicella vaccination","volume":"70","author":"Brisson M","year":"2003","journal-title":"Impact of vaccine efficacy on the epidemiology of VZV"},{"key":"e_1_2_6_44_2","first-page":"333","article-title":"Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age","volume":"17","author":"Grant DM","year":"1997","journal-title":"A cost-consequence model"},{"key":"e_1_2_6_45_2","first-page":"0628","article-title":"Analgesic therapy in postherpetic neuralgia","volume":"2","author":"Hempenstall K","year":"2005","journal-title":"A quantitative systematic review"},{"issue":"1","key":"e_1_2_6_46_2","first-page":"S91","article-title":"Postherpetic neuralgia","volume":"178","author":"Watson CPN.","year":"1998","journal-title":"The importance of preventing this intractable end-stage disorder"},{"key":"e_1_2_6_47_2","first-page":"95","article-title":"Antiviral therapies for herpes zoster infections","volume":"2","author":"Smith KJ","year":"2000","journal-title":"Are they economically justifiable?"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1086\/510206"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2007.01231.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2007.01231.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:29:03Z","timestamp":1762187343000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2007.01231.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1532-5415.2007.01231.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01231.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}